Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)

buy sell

Top Analyst Upgrades and Downgrades: GoPro, Illumina, Mattel, Match, Peabody, Petrobras, Wayfair, Yahoo and More

Stocks were indicated lower on Thursday after having been in positive territory in the wee-hours of the futures trading. Another rally has been used as an opportunity to sell, even ...
Read Full Story »
biotech word cloud

Short Sellers Increase Bets in Major Biotechs

The short interest data are out for the January 15 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can ...
Read Full Story »
Test tubes

Short Interest Remains Mixed for Major Biotechs

The short interest data are out for the December 31 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can ...
Read Full Story »
biotech word cloud

Short Interest Remains Mixed in Major Biotechs

The short interest data are out for the December 15 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can ...
Read Full Story »
ThinkstockPhotos-474136438

Insider Selling Highlights: Cisco, Shake Shack and More (Updated)

You talk about a roller-coaster ride, this past week in the stock market was the epitome. Following a huge rally after the Federal Reserve raised rates for the first time ...
Read Full Story »
biotech word cloud

Mixed Views on Major Biotech Short Interest

The short interest data are out for the November 30 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can ...
Read Full Story »
Test tubes

Short Sellers Run for Cover From Major Biotechs

The short interest data are out for the November 13 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can ...
Read Full Story »
Hepatitis Virus

Short Sellers Run for Cover From Major Biotechs

The short interest data are out for the October 30 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can ...
Read Full Story »
Hepatitis Virus

Short Sellers Become More Selective on Leading Biotechs

The short interest data are out for the October 15 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can ...
Read Full Story »
Automatic Inspection Machine - Ampules

Q3 Worst for Biotech in 7 Years: Which Large Cap Leaders to Buy Now

After racing to all-time highs in late July, the Nasdaq Biotechnology Index (NBI) and the NYSE Arca Biotechnology Index (BTK) then proceeded to decline 18.0% and 18.2% respectively. What really ...
Read Full Story »
Biotechnology word cloud

Short Sellers Increase Bets in Major Biotechs

The short interest data are out for the September 30 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can ...
Read Full Story »
generic drugs

Why Merrill Lynch Now Favors Large Cap Leaders in Biotech

Since the peak of the biotech index in late July, the industry has dropped a staggering 24% through the end of the third quarter, versus the 10% drop in the ...
Read Full Story »
investing

How the Top Biotechs Handled the Valuation Shock

Late Monday morning, the U.S. broad markets took a sharp downturn, led by a drop in the health care sector. The markets were pulled down, as it seemed that a ...
Read Full Story »
Biotechnology word cloud

Short Sellers Increase Bets in Major Biotech

The short interest data are out for the September 15 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can ...
Read Full Story »
Money, US, $100 bills

Why Oppenheimer Says Alexion Is a Cheap Buy Now

The biotech and pharmaceutical industries were hit hard recently when a presidential candidate posited via Twitter that drug prices were absurdly high. This caused a massive sell-off in the stocks. ...
Read Full Story »